Cantor Fitzgerald & Co.Morgan Stanley & Co. LLCLeerink Partners LLCJefferies LLC
Description
On October 20, 2026, Disc Medicine, Inc. entered into an Underwriting Agreement for an underwritten public offering of common stock. The Company raised approximately $422.4 million through the sale of 6 million shares at $75.00 per share. Additionally, there is an option for underwriters to purchase up to 900,000 more shares within 30 days
Who to call at Disc, and when
A new round usually means Disc is about to hire and buy. The teams that reach out first get the meeting.
An alert the day Disc raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Disc, from your own LinkedIn network
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Disc
Location
Watertown, Massachusetts, United States
About
Disc Medicine, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Disc raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
WatertownBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharma